-
China revises drug administration regulations to spur innovation, tighten oversight
2026-01-28
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
-
NMPA to enhance drug regulation under revised rules — committed to a people-centered healthy policy and strengthen high-effect regulation
2026-01-08
The revised Regulation aims to further encourage drug research and innovation, strengthen the whole life-cycle control of drugs and provide a solid legal guarantee for high-level drug safety and the high-quality development of the pharmaceutical industry.
-
Revision and Release of the Good Manufacturing Practice for Medical Devices
2025-12-24
On November 4, the National Medical Products Administration (NMPA) released the revised version of the Good Manufacturing Practice for Medical Devices (hereinafter referred to as the GMP). The new GMP for medical devices shall come into effect as of November 1, 2026.
-
NMPA Announcement on Issuing the Opinions on Deepening the Reform of Cosmetics Regulation and Promoting High-Quality Industry Development
2025-12-22
The release of the Opinions is an important measure by the NMPA to implement the strategic deployment of the Party Central Committee and the State Council on comprehensive deepening of reform and promoting high-quality development. It will better safeguard the people's demand for cosmetics and inject a strong impetus into the high-quality development of the cosmetics industry.
-
Li Li meets with head of BPOM of Indonesia
2025-11-13
On Nov 11, Li Li, commissioner of the National Medical Products Administration (NMPA), met in Beijing with a delegation led by Taruna Ikrar, head of the Food and Drug Supervisory Authority (BPOM) of Indonesia.
-
Yang Sheng meets with WHO officials
2025-11-12
Yang Sheng, deputy commissioner of the National Medical Products Administration (NMPA), met with Rogerio Gaspar, Director of the Regulation and Prequalification Department of the World Health Organization (WHO) and WHO Representative to China, Martin Taylor, in Beijing on Nov 7.
